| 注册
首页|期刊导航|中外医学研究|婴幼儿尿路感染的病原菌和头孢哌酮/舒巴坦疗效分析

婴幼儿尿路感染的病原菌和头孢哌酮/舒巴坦疗效分析

段正刚

中外医学研究Issue(27):112-113,114,3.
中外医学研究Issue(27):112-113,114,3.

婴幼儿尿路感染的病原菌和头孢哌酮/舒巴坦疗效分析

The Analysis of the Pathogenic Bacteria and the Effects of Cefoperazone/Sulbactam in the Treatment of Urinary Tract Infections in Infants

段正刚1

作者信息

  • 1. 南江县人民医院 四川 南江 636600
  • 折叠

摘要

Abstract

Objective:To research the distributions of pathogenic bacteria and the effects of Cefoperazone/Sulbactam in the treatment of urinary tract infection in infants.Method:Retrospective analysis 144 cases of infants with urinary tract infections in our hospital from March 2010 to March 2014,the patients did the urine separation and culture of middle urine.According to laboratory and susceptibility testing select the appropriate antibiotic in different course,to analysis the value of Cefoperazone/Sulbactam in the treatment of urinary tract infections in infants.Result:The results of urine culture with 76 cases positive,positive rate of 52.8%(76/144).In positive Gram-negative bacteria 67 cases,accounting for 88.2%(67/76).Gram-positive bacteria 9 cases,accounting for 11.8%(9/76).Escherichia coli 61 cases,accounting for 80.3%(61/76),Enterococcus 9 cases,accounting for 11.8%(9/76),Cefoperazone/Sulbactam was treated for the 104 patients who were treated ineffective with Cefotaxime,101 cases were cure,the rate of cure was 97.1%(101/104).Conclusion:Gram-negative bacteria (Escherichia coli) is the first causes of urinary tract infections in infants,followed by Gram-positive bacteria(Enterococcus),Cefoperazone/Sulbactam is more effective than conventional antibiotics in infants with urinary tract infections.

关键词

头孢哌酮/舒巴坦/婴幼儿/尿路感染

Key words

Cefoperazone/Sulbactam/Infants/Urinary tract infection

分类

医药卫生

引用本文复制引用

段正刚..婴幼儿尿路感染的病原菌和头孢哌酮/舒巴坦疗效分析[J].中外医学研究,2014,(27):112-113,114,3.

中外医学研究

1674-6805

访问量0
|
下载量0
段落导航相关论文